Longitudinal IP-10 Serum Levels Are Associated with the Course of Disease Activity and Remission in Patients with Rheumatoid Arthritis. [electronic resource]
- Clinical and vaccine immunology : CVI Aug 2017
Publication Type: Journal Article
1556-679X
10.1128/CVI.00060-17 doi
Antirheumatic Agents--therapeutic use Arthritis, Rheumatoid--blood Chemokine CXCL10--blood Disease Progression Female Humans Longitudinal Studies Male Middle Aged Point-of-Care Systems Retrospective Studies Severity of Illness Index